10 31 25 (Topiramate 25 mg)

Pill imprint 10 31 25 has been identified as Topiramate 25 mg.

Topiramate is used in the treatment of obesity; bipolar disorder; migraine prevention; fibromyalgia; vulvodynia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 10 31 25

Topiramate 25 mg 10 31 25
Topiramate
Imprint:
10 31
25
Strength:
25 mg
Color:
White
Size:
5.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Torrent Pharmaceuticals
National Drug Code (NDC):
13668-0031
Inactive Ingredients:
silicon dioxide colloidal
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0824 Stat RX USA LLC (repackager)
43063-0094 PDRX Pharmaceuticals Inc (repackager)
68387-0558 Keltman Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)